HealthMedical
World's First Hepatitis B Functional Cure mRNA Drug in China
Chinese researchers in Nanjing developed CPU-YL01, the world's first mRNA drug targeting a functional cure for Hepatitis B, now in Phase I trials.
—6 min read
Tag
3 articles
Chinese researchers in Nanjing developed CPU-YL01, the world's first mRNA drug targeting a functional cure for Hepatitis B, now in Phase I trials.
China approved 11 domestically developed new-target drugs in H1 2026, exceeding 2025's total, with world-first therapies and record out-licensing deals.
Chinese-developed ocean drugs account for nearly 30% of approved marine drugs globally, as Beijing issues landmark policy to boost the sector.